GlassScriptPhysician profile
Jerry W Iery
NPI 1255416384
$932.84
in general payments reported to CMS, 2019-2025
15 companies · $13.77 in 2025
The $13.77 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $121 · 2022: $193 · 2023: $294 · 2024: $312 · 2025: $13.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $619.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $619.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $374.90 | 2022-2025 | Strensiq |
| Lilly USA, LLC | $116.63 | 2021-2024 | Mounjaro |
| Glaxosmithkline, LLC. | $105.26 | 2022-2024 | Bexsero, Shingrix |
| Astellas Pharma US INC | $88.70 | 2023-2024 | Veozah, Myrbetriq |
| Abbvie INC. | $49.91 | 2023-2024 | |
| Xeris Pharmaceuticals, INC. | $46.67 | 2021-2022 | |
| Novo Nordisk INC | $31.65 | 2021-2022 | |
| Axsome Therapeutics, INC. | $22.69 | 2024 | Auvelity |
| Ultragenyx Pharmaceutical INC. | $17.37 | 2021 | |
| Exact Sciences Corporation | $16.52 | 2024 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $16.40 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $15.14 | 2021 | |
| Heartflow, INC. | $14.95 | 2024 | |
| Amgen INC. | $13.47 | 2024 | Repatha |
| Genentech USA, INC. | $2.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Iery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.